|
 |
Cutbacks Disrupt Alzheimer Registry
(Source: The Plain Dealer) - Since the late 1980s, families and patients in the Cleveland area have participated in an Alzheimer's registry which compiled information to help researchers track the course of the disease. Data from more than 2,300 individuals are compiled in the data bank. Scientists hope that this information could some day point to a cure.
How to Tell If It's Alzheimer's
(Source: Malden Observer) - A Malden Observer reader wrote: "My older sister has been the 'glue' that held our family together ever since our parents died at a rather young age. She had a successful career and was very active in the community until a few years ago. Over the last few months her whole demeanor has changed. She forgets about family celebrations and then claims no one told her about them. She has had two minor car accidents but insists neither was her fault. Three of our parent's siblings had Alzheimer's so now I'm worried my sister may be facing the same fate. What should we be looking for?"
Patent Applied for Neurodegenerative Biomarkers
(Source: GEN) - Power3 Medical Products announced the filing of a patent application for 47 new biomarkers for use in the early diagnosis and detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS.
Research Awards to Alzheimer's Scientists
(Source: MetLife Foundation) - The winners of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease were announced today. Winners included
Dr. David Holtzman for his pioneering work in molecular biology examining the early stages of Alzheimer's and Dr. Berislav for his research defining the impact that blood flow plays in Alzheimer's disease.
Alzheimer's Agreement Extended
(Source: TorreyPines Therapeutics) - TorreyPines Therapeutics announced the extension of a collaborative agreement with Eisai involving novel molecules to treat Alzheimer's disease.
|
|